How Wellbutrin 150mg SR is Prescribed
Wellbutrin (bupropion) 150 mg sustained-release is typically initiated at 150 mg once daily in the morning for the first 3 days, then increased to 150 mg twice daily (maximum 300 mg/day) if tolerated, with the second dose given before 3 PM to minimize insomnia risk. 1
Standard Dosing Algorithm
Initial Titration
- Days 1-3: Start with 150 mg orally once daily in the morning
- Day 4 onwards: Increase to 150 mg twice daily if tolerated
- Maximum dose: 300 mg per day (150 mg twice daily)
The gradual titration helps minimize side effects, particularly insomnia and agitation 1.
Timing Considerations
The second daily dose must be taken before 3 PM to reduce insomnia risk 2. This timing is critical because bupropion has activating properties that can interfere with sleep if taken late in the day 3.
Context-Specific Prescribing
For Depression
When prescribing for depression, the standard titration applies. Bupropion is particularly useful in patients with:
- Apathetic or low-energy depression (activating effect) 2
- Concerns about sexual side effects (lower risk than SSRIs)
- Comorbid smoking cessation needs 3
A full therapeutic trial requires 4-8 weeks before assessing efficacy 2.
For Smoking Cessation
- Initiate 1-2 weeks prior to the target quit date 1
- Follow the same titration schedule (150 mg daily for 3 days, then 150 mg twice daily)
- Duration: 7-12 weeks, with possible extension to 6 months-1 year 1
For Weight Management (as part of naltrexone-bupropion ER)
When used in combination products for obesity, bupropion 90 mg is combined with naltrexone 8 mg per tablet, with weekly dose escalation 3.
Dose Adjustments for Special Populations
Renal Impairment
- Moderate to severe renal impairment: Reduce frequency and/or dose 4
- End-stage renal disease: Avoid or use with extreme caution
- Rationale: Metabolites (hydroxybupropion, threohydrobupropion) accumulate 2-3 fold in renal failure 4
Hepatic Impairment
- Severe hepatic cirrhosis: Bupropion Cmax and AUC increase by ~70% and 3-fold respectively 4
- Consider reduced dosing frequency or lower total daily dose
- Monitor closely for adverse effects
Elderly Patients
Start at the lower end of the dosing range (150 mg once daily) and titrate more slowly, as older patients may be more sensitive to activating effects 2.
Critical Contraindications and Warnings
Absolute Contraindications
- Seizure disorders or conditions that lower seizure threshold (stroke, brain metastases, head trauma) 1
- Concurrent or recent (within 14 days) MAO inhibitor use 1
- Eating disorders (anorexia, bulimia) - increased seizure risk
- Abrupt discontinuation of alcohol or benzodiazepines
Important Warnings
- Seizure risk is dose-dependent: Keep total daily dose ≤300 mg for SR formulation and avoid exceeding 150 mg per single dose 1
- Neuropsychiatric monitoring: Although black box warnings have been removed by the FDA, monitor for depression worsening, suicidal ideation, or behavioral changes, especially in patients under 24 years 1, 5
- Hypertension: Monitor blood pressure, particularly when used in combination products 3
Common Pitfalls to Avoid
- Late-day dosing: Taking the second dose after 3 PM commonly causes insomnia 2
- Too-rapid titration: Skipping the 3-day initial period increases side effect risk
- Exceeding maximum dose: Doses >300 mg/day significantly increase seizure risk
- Using in agitated patients: Bupropion's activating properties can worsen agitation 2
- Ignoring drug interactions: Bupropion inhibits CYP2D6; adjust doses of drugs metabolized by this pathway 3
Monitoring and Follow-up
- Week 1: Assess tolerability, particularly insomnia, anxiety, or agitation
- Weeks 4-8: Evaluate therapeutic response for depression
- Ongoing: Monitor for neuropsychiatric symptoms, blood pressure (if applicable), and weight changes
If no response after 4-8 weeks at therapeutic dose, consider switching to an alternative agent rather than exceeding maximum recommended doses 2.